CytomX Therapeutics (CTMX) Stock Chart & Stock Price History $2.23 +0.10 (+4.69%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.22 0.00 (-0.22%) As of 05/23/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CytomX Therapeutics Stock Price Performance The CytomX Therapeutics (CTMX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 27.43%, with a year-to-date return of 116.50%. In the past month, the stock has increased 191.20%, reflecting recent market activity. As of the latest close, CytomX Therapeutics traded at $2.23 with a market cap of $179.79 million and volume of 3.08 million shares. Five years ago, the stock traded at $9.41, representing a 76.30% decrease over that period. At the time, it had a market cap of $427.55 million and a volume of 402,900 shares. Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.69%1 Month Performance+191.20%3 Month Performance+199.69%Year-To-Date Performance+116.50%1 Year Performance+27.43%5 Year Performance-76.30% CTMX Stock Chart for Saturday, May, 24, 2025 CTMX Chart by TradingView CytomX Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$2.13$2.23+4.69%$2.29$2.033.08 million shs$179.79 million05/22/2025$2.04$2.13+4.41%$2.23$2.013.72 million shs$171.72 million05/21/2025$2.06$2.04-0.97%$2.11$1.982.79 million shs$164.47 million05/20/2025$2.13$2.06-3.29%$2.15$1.977.59 million shs$166.08 million05/19/2025$2.03$2.13+4.93%$2.25$2.004.58 million shs$171.72 million05/16/2025$2.00$2.03+1.50%$2.16$1.955.85 million shs$163.66 million05/15/2025$2.38$2.00-15.97%$2.50$1.879.14 million shs$161.24 million05/14/2025$2.50$2.38-4.80%$2.38$2.017.90 million shs$191.88 million05/13/2025$2.13$2.50+17.37%$2.55$1.8624.21 million shs$201.55 million05/12/2025$0.93$2.13+129.43%$2.18$1.65113.23 million shs$171.72 million Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$1.10$0.93-15.21%$1.30$0.9115.25 million shs$74.85 million05/08/2025$0.97$1.10+12.54%$1.19$0.985.70 million shs$88.28 million05/07/2025$0.97$0.97-0.10%$1.00$0.922.04 million shs$78.44 million05/06/2025$0.96$0.97+1.33%$1.04$0.902.40 million shs$78.53 million05/05/2025$0.80$0.96+19.85%$1.00$0.844.44 million shs$77.49 million05/02/2025$0.76$0.80+5.90%$0.83$0.761.42 million shs$64.24 million05/01/2025$0.74$0.76+1.75%$0.77$0.72716,246 shs$60.66 million04/30/2025$0.65$0.74+14.23%$0.74$0.631.65 million shs$59.62 million04/29/2025$0.71$0.65-7.95%$0.72$0.641.98 million shs$52.19 million04/28/2025$0.71$0.71-0.30%$0.77$0.703.97 million shs$56.70 million04/25/2025$0.77$0.71-7.29%$0.77$0.70715,524 shs$56.87 million04/24/2025$0.73$0.77+4.88%$0.77$0.68785,239 shs$61.34 million04/23/2025$0.74$0.73-0.80%$0.78$0.72682,809 shs$58.49 million Related Companies ArriVent BioPharma Stock Chart Day One Biopharmaceuticals Stock Chart Trevi Therapeutics Stock Chart Immatics Stock Chart Vir Biotechnology Stock Chart Sionna Therapeutics Stock Chart Evolus Stock Chart Replimune Group Stock Chart Pharming Group Stock Chart Dianthus Therapeutics Stock Chart Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTMX) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTMX Stock Free CTMX Stock Alerts